Monoclonal antibodies represent an exciting class of therapeutics against respiratory viral
infections. Notwithstanding their specificity and affinity, the conventional parenteral …

Dry powder inhalers (DPIs) are drug–device combination products where the complexity of
the formulation, its interaction with the device, and input from users play important roles in …

Spray-dried nanoparticle-in-microsphere formulations, composed of aluminum oxide
nanoparticles (NPs), zinc oxide, zinc oxide NPs and cellulose nanocrystals (CNCs), with …

Lung cancer represents a marked global public health concern. Despite existing treatment
modalities, the average 5‑year survival rate for patients with patients with lung cancer is …

Introduction Monoclonal antibodies (mAbs) should be administered by inhalation rather than
parenterally to improve their efficiency in lung diseases. However, the pulmonary …

Monoclonal antibodies (mAbs) are an important and growing class of biotherapeutic drugs.
Method development for the characterization of critical quality attributes, including higher …

Dry powder inhaler (DPI) products are commonly formulated as a mixture of micronized drug
particles and large carrier particles, with or without additional fine particle excipients …

Biological products, including vaccines, blood components, and recombinant therapeutic
proteins, are derived from natural sources such as humans, animals, or microorganisms and …

Reversible protein precipitates (protein microbeads) have been developed using Shirasu
porous glass (SPG) membrane emulsification. Microbeads have a mean size of a few …

Low oral absorption and extensive first pass metabolism of progesterone is reported for
many oral formulations which warrants investigation into other routes of administration. It is …